Where can I find QMDT's financial statements?

Quick-Med Technologies, Inc. (QMDT)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for QMDT?

Quick-Med Technologies, Inc. (QMDT) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does QMDT update its statements?

Quick-Med Technologies, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

QMDT

Quick-Med Technologies, Inc.

OTC·Medical, Pharmaceuticals · Healthcare

$0.00$0.00+0.00%

Market cap$29.88K·Market closed·Aug 25 8:00 PM UTC

USD · values shown as reported

Line item	FY 2009	FY 2010	FY 2011	FY 2012	FY 2013	Trend
Revenue	$1.00M−26.2%	$993.94K−1.1%	$1.04M+4.6%	$997.50K−4.0%	$928.49K−6.9%
Cost of revenue	$259.35K+361.8%	$284.91K+9.9%	$347.37K+21.9%	$325.88K−6.2%	$280.51K−13.9%
Gross profit	$745.38K−42.9%	$709.04K−4.9%	$692.21K−2.4%	$671.62K−3.0%	$647.99K−3.5%
Research & development	$1.06M−31.6%	$1.22M+15.1%	$1.02M−16.4%	$847.35K−17.2%	$519.84K−38.7%
General & administrative	—	—	—	—	$467.20	—
Selling & marketing	—	—	—	—	$466.74K	—
SG&A (combined)	$1.38M−27.7%	$1.50M+9.1%	$1.65M+10.2%	$998.39K−39.6%	$467.20K−53.2%
Total operating expenses	$2.51M−28.9%	$2.79M+11.3%	$2.74M−1.8%	$1.91M−30.4%	$1.02M−46.4%
Operating income	−$1.77M+20.7%	−$2.08M−18.1%	−$2.05M+1.6%	−$1.24M+39.6%	−$376.08K+69.6%
Interest income	$2.29K+4.3%	$2.02K−12.0%	$2.13K+5.7%	$1.38K−35.4%	$7.65K+456.2%
Interest expense	$259.87K+55.2%	$1.47M+464.6%	$449.14K−69.4%	$449.96K+0.2%	$446.19K−0.8%
Other income / (expense), net	−$257.58K−55.9%	−$1.47M−468.8%	−$251.43K+82.8%	−$448.58K−78.4%	−$337.00K+24.9%
Income before tax	−$2.02M+15.4%	−$3.55M−75.5%	−$2.30M+35.1%	−$1.69M+26.8%	−$713.07K+57.7%
Income tax expense	$2.29K	$2.02K−12.0%	—	$1.38K	—
Net income	−$2.02M+15.4%	−$3.55M−75.5%	−$2.30M+35.1%	−$1.69M+26.8%	−$713.07K+57.7%

EPS (basic)	−$0.07+15.9%	−$0.11−68.2%	−$0.07+36.5%	−$0.05+35.3%	−$0.02+57.7%
EPS (diluted)	−$0.07+15.9%	−$0.11−68.2%	−$0.07+36.5%	−$0.05+35.3%	−$0.02+57.7%
Weighted avg shares (basic)	30,935,633	31,260,738	32,951,263	37,346,154	37,346,154
Weighted avg shares (diluted)	30,935,633	31,260,738	32,951,263	37,346,154	37,346,154

Depreciation & amortization	$71.91K−0.9%	$70.61K−1.8%	$68.36K−3.2%	$64.20K−6.1%	$37.02K−42.3%
EBITDA	−$1.69M+21.4%	−$2.01M−19.0%	−$1.79M+11.3%	−$1.17M+34.3%	−$229.86K+80.4%

Frequently Asked Questions About QMDT

Where can I find QMDT's financial statements?: Quick-Med Technologies, Inc. (QMDT)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for QMDT?: Quick-Med Technologies, Inc. (QMDT) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does QMDT update its statements?: Quick-Med Technologies, Inc. files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2009

FY 2010

FY 2011

FY 2012

FY 2013

Trend

Revenue

$1.00M−26.2%

$993.94K−1.1%

$1.04M+4.6%

$997.50K−4.0%

$928.49K−6.9%

Cost of revenue

$259.35K+361.8%

$284.91K+9.9%

$347.37K+21.9%

$325.88K−6.2%

$280.51K−13.9%

Gross profit

$745.38K−42.9%

$709.04K−4.9%

$692.21K−2.4%

$671.62K−3.0%

$647.99K−3.5%

Research & development

$1.06M−31.6%

$1.22M+15.1%

$1.02M−16.4%

$847.35K−17.2%

$519.84K−38.7%

General & administrative

—

$467.20

—

Selling & marketing

—

$466.74K

—

SG&A (combined)

$1.38M−27.7%

$1.50M+9.1%

$1.65M+10.2%

$998.39K−39.6%

$467.20K−53.2%

Total operating expenses

$2.51M−28.9%

$2.79M+11.3%

$2.74M−1.8%

$1.91M−30.4%

$1.02M−46.4%

Operating income

−$1.77M+20.7%

−$2.08M−18.1%

−$2.05M+1.6%

−$1.24M+39.6%

−$376.08K+69.6%

Interest income

$2.29K+4.3%

$2.02K−12.0%

$2.13K+5.7%

$1.38K−35.4%

$7.65K+456.2%

Interest expense

$259.87K+55.2%

$1.47M+464.6%

$449.14K−69.4%

$449.96K+0.2%

$446.19K−0.8%

Other income / (expense), net

−$257.58K−55.9%

−$1.47M−468.8%

−$251.43K+82.8%

−$448.58K−78.4%

−$337.00K+24.9%

Income before tax

−$2.02M+15.4%

−$3.55M−75.5%

−$2.30M+35.1%

−$1.69M+26.8%

−$713.07K+57.7%

Income tax expense

$2.29K

$2.02K−12.0%

—

$1.38K

—

Net income

−$2.02M+15.4%

−$3.55M−75.5%

−$2.30M+35.1%

−$1.69M+26.8%

−$713.07K+57.7%

EPS (basic)

−$0.07+15.9%

−$0.11−68.2%

−$0.07+36.5%

−$0.05+35.3%

−$0.02+57.7%

EPS (diluted)

−$0.07+15.9%

−$0.11−68.2%

−$0.07+36.5%

−$0.05+35.3%

−$0.02+57.7%

Weighted avg shares (basic)

30,935,633

31,260,738

32,951,263

37,346,154

Weighted avg shares (diluted)

30,935,633

31,260,738

32,951,263

37,346,154

Depreciation & amortization

$71.91K−0.9%

$70.61K−1.8%

$68.36K−3.2%

$64.20K−6.1%

$37.02K−42.3%

EBITDA

−$1.69M+21.4%

−$2.01M−19.0%

−$1.79M+11.3%

−$1.17M+34.3%

−$229.86K+80.4%